Recruiting studies: Haemophilia A Moderate Or Severe

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Phase 1/Phase 2 · 2 location(s) · Hoffmann-La Roche · NCT07226206 Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa
Phase 3 · 21 location(s) · Swedish Orphan Biovitrum · NCT06716814 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With
Phase 1/Phase 2 · 14 location(s) · Hoffmann-La Roche · NCT05987449 A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Phase 3 · 34 location(s) · Pfizer · NCT05611801 Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Phase 3 · 75 location(s) · Pfizer · NCT05145127

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.